Steadman Philippon Research Institute and Vail Health renew five-year partnership

Steadman Philippon Research Institute and Vail Health have renewed their partnership with a five-year commitment. The partners say the collaboration has advanced orthopaedic and cancer research and will focus on deepening impact and exploring regenerative medicine and longevity.

Steadman Philippon Research Institute and Vail Health have renewed a landmark partnership with a five-year commitment. The renewal follows a decade of collaboration that SPRI leaders describe as critical to the institute’s growth. The partners say their joint work has advanced orthopaedic and cancer research and contributed to global medical knowledge. Many shared research projects are ongoing and the agreement is framed as a way to deepen that work. Key facts: - The partnership between SPRI and Vail Health has been renewed with a five-year commitment. - Marc J. Philippon, M.D., Chairman of SPRI, said SPRI experienced tremendous growth and that the partnership was critical to much of that success over the past 10 years. - The institutions report that their collaboration has advanced orthopaedic and cancer research and contributed to global medical knowledge. - Many shared research projects are ongoing. - The partners said the next five years will focus on deepening impact and pursuing new frontiers in regenerative medicine and longevity. Summary: The five-year renewal formalizes continued collaboration that partners say has supported SPRI’s growth and advances in orthopaedic and cancer research. The organizations say their shared projects are ongoing, and the next five years will emphasize deepening research impact and pursuing work in regenerative medicine and longevity.